Spots Global Cancer Trial Database for Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone
Official Title: Clinical Phase II, Multicenter, Open-label Study Evaluating iNduction, Consolidation and Maintenance With Isatuximab (SAR650984), Carfilzomib, LEnalidomide and Dexamethasone (I-KRd) in Primary Diagnosed High-risk Multiple Myeloma paTients
Study ID: NCT03104842
Conditions
Study Description
Brief Summary: A Clinical Phase II, multicenter, Open-label study evaluating iNduction, consolidation and maintenance treatment with Isatuximab (SAR650984), Carfilzomib, LEnalidomide and Dexamethasone (I-KRd) in Primary diagnosed high-risk multiple myeloma paTients
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Vivantes Am Urban, Berlin, , Germany
Campus Benjamin Franklin Charite Berlin, Berlin, , Germany
Vivantes Klinikum Neukölln, Berlin, , Germany
Städt. Kliniken Bielefeld Klinikum Mitte, Bielefeld, , Germany
Johanniter-Krankenhaus Bonn, Bonn, , Germany
Uniklinikum Chemnitz, Chemnitz, , Germany
St. Antonius Hospital, Eschweiler, , Germany
Universitätsklinikum Essen, Essen, , Germany
Asklepios Altona, Hamburg, , Germany
University Hospital Hamburg Eppendorf, Hamburg, , Germany
University Hospital Heidelberg, Heidelberg, , Germany
Uniklinik Köln, Koln, , Germany
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, , Germany
Philipps-Universität Marburg, Marburg, , Germany
Kliniken Maria Hilf GmbH, Klinik für Hämatologie, Onkologie und Gastroenterologie, Mönchengladbach, , Germany
Klinikum Osnabrück, Osnabrück, , Germany
Universitätsklinikum Tuebingen, Tuebingen, , Germany
Contact Details
Name: Katja Weisel, Prof
Affiliation: Universitätsklinikum Hamburg-Eppendorf
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
